Trial intelligence / Profile preview

Pharmacokinetics of colistin in bronchoalveolar lavage in Gram-negative pulmonary infections

2007-005045-38Phase 4Completed

Sponsor
IRCCS San Matteo Foundation
Start
Nov 2007
Modality
Peptides
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of colistin in pneumonia and pulmonary infection, sponsored by IRCCS San Matteo Foundation. Primary endpoints: Colistin pharmacokinetic parameters in ELF, plasma, and urine and Colistin pharmacodynamic parameters. Started Nov 2007; status: completed.

02

Drugs

colistin
03

Conditions

pneumoniapulmonary infection

Beyond the preview

Go deeper on 2007-005045-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-005045-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call